Lycera

Development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.

placeAnn Arbor, Michigan, United States calendar_todayFounded 2006 groups22 employees language lycera.com

Registered entities

Investor mix

5 investors on record; lead investors include InterWest Partners, Arch Venture Partners, Blackstone.

Investor typeCountShare
Venture capital480%
Private equity120%
Coming soon